Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06342492

Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Kansas City Heart Rhythm Research Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.

Detailed description

Cardiac resynchronization therapy with defibrillator(CRT-D) improves quality of life, functionality, and even mortality for select patients with severe heart failure with reduced ejection fraction (HFrEF). It traditionally consists of three leads placed endovascularly into the right atrium, right ventricle, and left ventricle (LV) \[typically placed into the CS\], known as biventricular pacing resynchronization (BVP-CRT), respectively, from which electrical stimulation enables improved cardiac synchrony. Nonetheless, the placement of a CRT-D is not without risks. Lead-related complication is high and CRT-D implantation fails in up to 30% of patients due to lead placement alone. Epicardial lead placement and CSP have been deemed viable alternatives to CRT-D. It has even been shown to be options in patients that fail conventional BVP-CRT. This is primarily due to increased accuracy, decreased complications, and even durability. However, guidelines for decision between a transthoracic approach and CSP is unclear, even more so after lead failure. Instead, this decision is currently individualized to the patient. There is a lack of prospective and head-to-head data between the two, and this study is aimed to compare transthoracic LV epicardial lead placement and CSP in patients with lead failure after BVP-CRT.

Conditions

Interventions

TypeNameDescription
OTHERCoronary Sinus Lead RevisionCoronary Sinus Lead Revision

Timeline

Start date
2023-11-07
Primary completion
2024-11-01
Completion
2024-12-01
First posted
2024-04-02
Last updated
2024-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06342492. Inclusion in this directory is not an endorsement.